ICD-10 Coding for Farxiga(E11.9, I50.23, N18.3)
Complete ICD-10-CM coding and documentation guide for Farxiga. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Farxiga
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E11.9 | Type 2 diabetes mellitus without complications | Use when Farxiga is prescribed for Type 2 Diabetes Mellitus. |
|
| I50.23 | Chronic systolic (congestive) heart failure | Use when Farxiga is prescribed for heart failure. |
|
| N18.3 | Chronic kidney disease, stage 3 (moderate) | Use when Farxiga is prescribed for CKD. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for Farxiga
Essential facts and insights about Farxiga
Primary ICD-10-CM Codes for farxiga
Decision Criteria
clinical Criteria
- Patient has Type 2 Diabetes Mellitus.
Applicable To
- Type 2 diabetes mellitus
Excludes
- Type 1 diabetes mellitus
Clinical Validation Requirements
- HbA1c ≥6.5%
- C-peptide ≥0.6 ng/mL
Code-Specific Risks
- Ensure correct diabetes type is documented.
Coding Notes
- Ensure documentation specifies Type 2 Diabetes.
I50.23 - Chronic systolic (congestive) heart failure
Use when Farxiga is prescribed for heart failure.
Applicable To
- Chronic heart failure
Excludes
- Acute heart failure
Clinical Validation Requirements
- BNP >100 pg/mL
Coding Notes
Document specific heart failure type.
N18.3 - Chronic kidney disease, stage 3 (moderate)
Use when Farxiga is prescribed for CKD.
Applicable To
- Moderate CKD
Excludes
- Acute kidney failure
Clinical Validation Requirements
- eGFR 30-59 mL/min/1.73m²
Coding Notes
Document specific CKD stage.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Long-term (current) use of oral hypoglycemic drugs
Z79.84Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Farxiga to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code E11.9.
Impact
Clinical: Misrepresentation of patient's condition., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation Strategy
Verify diabetes type with lab results., Use correct ICD-10 code.
Impact
Reimbursement: May affect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient treatment.
Mitigation Strategy
Always add Z79.84 for long-term use of oral antidiabetic drugs.
Impact
Incorrect sequencing of primary and secondary codes.
Mitigation Strategy
Follow ICD-10 guidelines for code sequencing.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Farxiga, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Farxiga
Use these documentation templates to ensure complete and accurate documentation for Farxiga. These templates include all required elements for proper coding and billing.
Type 2 Diabetes Management
Specialty: EndocrinologyRequired Elements
- Diagnosis
- Medication
- Lab results
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Farxiga? Ask your questions below.